Raymond James Financial Services Advisors’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$650K Sell
80,499
-2,446
-3% -$13.2K ﹤0.01% 2436
2024
Q2
$359K Sell
82,945
-350
-0.4% -$1.78K ﹤0.01% 2764
2024
Q1
$353K Buy
83,295
+1,461
+2% +$5.07K ﹤0.01% 2746
2023
Q4
$308K Buy
81,834
+10,362
+14% +$35.7K ﹤0.01% 2724
2023
Q3
$264K Sell
71,472
-780
-1% -$3.1K ﹤0.01% 2741
2023
Q2
$286K Sell
72,252
-50
-0.1% -$247 ﹤0.01% 2687
2023
Q1
$299K Sell
72,302
-505
-0.7% -$2.07K ﹤0.01% 2645
2022
Q4
$307K Buy
72,807
+24,400
+50% +$86.3K ﹤0.01% 2569
2022
Q3
$137K Buy
48,407
+6,037
+14% +$25.1K ﹤0.01% 2948
2022
Q2
$170K Buy
42,370
+3,355
+9% +$12.5K ﹤0.01% 2899
2022
Q1
$214K Sell
39,015
-3,015
-7% -$13.8K ﹤0.01% 2921
2021
Q4
$191K Sell
42,030
-2,182
-5% -$10.8K ﹤0.01% 2987
2021
Q3
$206K Buy
44,212
+695
+2% +$4.05K ﹤0.01% 2966
2021
Q2
$299K Buy
43,517
+1,261
+3% +$10K ﹤0.01% 2721
2021
Q1
$422K Buy
42,256
+16,986
+67% +$179K ﹤0.01% 2403
2020
Q4
$188K Sell
25,270
-60
-0.2% -$408 ﹤0.01% 2735
2020
Q3
$153K Buy
25,330
+580
+2% +$2.91K ﹤0.01% 2606
2020
Q2
$156K Buy
24,750
+750
+3% +$3.47K ﹤0.01% 2548
2020
Q1
$86K Buy
24,000
+3,815
+19% +$21.6K ﹤0.01% 2255
2019
Q4
$147K Buy
20,185
+421
+2% +$2.57K ﹤0.01% 2645
2019
Q3
$126K Buy
19,764
+1,464
+8% +$12.3K ﹤0.01% 2605
2019
Q2
$164K Buy
18,300
+6,539
+56% +$51.3K ﹤0.01% 2587
2019
Q1
$111K Buy
+11,761
New +$106K ﹤0.01% 2628
2017
Q2
Sell
-2,608
Closed -$21K 2531
2017
Q1
$21K Sell
2,608
-800
-23% -$7.64K ﹤0.01% 2367
2016
Q4
$26K Sell
3,408
-90
-3% -$911 ﹤0.01% 2275
2016
Q3
$44K Sell
3,498
-4,818
-58% -$45K ﹤0.01% 2212
2016
Q2
$83K Buy
8,316
+1,190
+17% +$18.1K ﹤0.01% 2124
2016
Q1
$94K Buy
+7,126
New +$69.2K ﹤0.01% 1907

Other funds holding CRMD